Dinglan Wu Selected Research

Orphan Nuclear Receptors

1/2021	Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer.
1/2021	Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
1/2018	Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.
1/2016	The emerging roles of orphan nuclear receptors in prostate cancer.
5/2015	Orphan nuclear receptor TLX functions as a potent suppressor of oncogene-induced senescence in prostate cancer via its transcriptional co-regulation of the CDKN1A (p21(WAF1) (/) (CIP1) ) and SIRT1 genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dinglan Wu Research Topics

Disease

16	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2008
15	Neoplasms (Cancer) 01/2022 - 12/2014
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 11/2017
2	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2018
2	Glioma (Gliomas) 01/2021 - 04/2020
2	Hypoxia (Hypoxemia) 12/2014 - 05/2014
1	Glioblastoma (Glioblastoma Multiforme) 04/2020
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Carcinogenesis 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2017
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2008

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2014
6	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022 - 01/2018
6	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2013
5	AndrogensIBA 01/2021 - 01/2016
5	Orphan Nuclear ReceptorsIBA 01/2021 - 05/2015
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2014
3	Cofilin 1IBA 01/2019 - 11/2017
2	Androgen Antagonists (Antiandrogens)IBA 01/2022 - 01/2013
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2022 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	LigandsIBA 01/2021 - 05/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 05/2015
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	ezrinIBA 04/2020
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 04/2020
1	Peptides (Polypeptides)IBA 01/2020
1	sipuleucel-T (APC8015)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	XenobioticsIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Long Noncoding RNAIBA 01/2019
1	Antisense RNA (Anti-Sense RNA)IBA 01/2019
1	3' Untranslated Regions (3' UTR)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	LuciferasesIBA 01/2019
1	ElementsIBA 11/2018
1	Estrogen ReceptorsIBA 11/2018
1	Abiraterone AcetateIBA 01/2018
1	AgarIBA 01/2018
1	EnzymesIBA 01/2018
1	abirateroneIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 11/2017
1	RNA (Ribonucleic Acid)IBA 11/2017
1	Actin Depolymerizing Factors (Cofilins)IBA 11/2017
1	CytokinesIBA 08/2017
1	Sirtuin 1IBA 05/2015
1	Ion Channels (Ion Channel)IBA 12/2014
1	bicalutamide (Casodex)FDA LinkGeneric 01/2013
1	Hormones (Hormone)IBA 01/2013
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2008

Therapy/Procedure

8	Castration 01/2022 - 01/2018
4	Therapeutics 01/2022 - 01/2020
1	Immunotherapy 01/2020